Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST RENAL CELL CARCINOMA CONTENT
Choosing Among Frontline IO/TKI Regimens in Advanced RCC
Oncologists Weigh Tivozanib Data in Pretreated Metastatic RCC
Rapid Disease Control Drives Frontline Choices in Metastatic ccRCC
Selecting Second-Line Therapy After ICI Progression in Metastatic ccRCC
Optimizing Adjuvant IO in Renal Cell Carcinoma Post-Nephrectomy
IO/TKI Combinations Shift the Standard of Care in Renal Cell Carcinoma
Second-Line Management After ICI in Metastatic Clear Cell RCC
Managing Toxicity and Safety of Belzutifan in ccRCC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement